Clinical experience with gabapentin in patients with bipolar or schizoaffective disorder: Results of an open-label study

Journal of Clinical Psychiatry

Volumn 60, Issue 4, 1999, Pages 245-248

  Cabras, Pier L ^a   Hardoy, M Julieta ^a   Hardoy, M Carolina ^a   Carta, Mauro G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; TRANQUILIZER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPOMANIA; MALE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RATING SCALE; SCHIZOIDISM; SOMNOLENCE; TREATMENT OUTCOME;

EID: 0032910702     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v60n0408     Document Type: Article

References (21)

1. Lambert PA, Carraz G, Borselli S, et al. Action neuro-psychotrope d'un nouvel anti-épileptiche: le Dépamide. Ann Méd Psychol (Paris) 1966;1: 707-710
2. Okuma T, Kishimoto A, Inoue K, et al. Antimanic and prophylactic effects of carbamazepine on manic depressive psychosis. Folia Psychiatr Neurol Jpn 1973;27:283-297
3. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 1994;151(suppl 12):1-36
4. Calabrese JR. Lamotrigine in treatment refractory manic depression. Presented at the International Conference on New Directions in Affective Disorders. September 3-8, 1995; Jerusalem, Israel
5. McElroy SL, Keck PE Jr. Drugs for treatment of bipolar disorder: anticonvulsants. In: Schatzberg AF, Nemeroff CB, eds. Textbook of Psychopharmacology. Washington, DC: American Psychiatric Press; 1995:351-356
6. Taylor CP. Emerging perspectives on the mechanism of action of gabapentin. Neurology 1994;44(suppl 5):S10-S16
7. Stanton SP, Keck PE Jr, McElroy SL. Treatment of acute mania with gabapentin [letter]. Am J Psychiatry 1997;154:287
8. Shaffer CB, Shaffer LC. Gabapentin in the treatment of bipolar disorder [letter]. Am J Psychiatry 1997;154:291-292
9. Bennet J, Goldman WT, Suppes T. Gabapentin for treatment of bipolar and schizoaffective disorders [letter]. J Clin Psychopharmacol 1997;17: 141-142
10. McElroy SL, Sontullo C, Keck PE Jr, et al. A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder. Ann Clin Psychiatry 1997; 9:99-103
11. Short C, Cooke L. Hypomania induced by gabapentin. Br J Psychiatry 1995;166:679-680
12. Lee DO, Steingard RJ, Cesena M. Behavioral side effects of gabapentin in children. Epilepsia 1996;37:87-90
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
14. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976;218-222
15. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812
16. Ramsay RE. Clinical efficacy and safety of gabapentin. Neurology 1994;44(suppl 5):S23-S30
17. Van Kammen DP. γ-Aminobutyric acid (GABA) and the dopamine hypothesis of schizophrenia. Am J Psychiatry 1977;134:138-143
18. Berrettini WH, Post RM. GABA in affective illness. In: Post RM, Ballenger JC, eds. Neurobiology of Mood Disorders. Baltimore, Md: Williams & Wilkins; 1984:673-685
19. Lloyd KG, Morselli PL. Psychopharmacology of GABAergic drugs. In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. New York, NY: Raven Press; 1987:183-95
20. Post RM, Ballenger JC, Hare TA. Cerebrospinal fluid GABA in normals and patients with affective disorders. Brain Res Bull 1980;5:755-759
21. Gee NS, Brown JP, Dissanayake VU, et al. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 1996;271:5768-5776